Advertisement

Ventricular Arrhythmias

  • Sohaib Tariq
  • Howard A. CooperEmail author
Chapter
  • 4 Downloads

Abstract

Ventricular arrhythmias encompass a spectrum from isolated premature ventricular complexes to ventricular fibrillation, manifest by clinical syndromes ranging from palpitations to sudden cardiac death. Episodes may be isolated or recurrent (electrical storm). Myocardial ischemia, underlying structural heat disease, and channelopathies are the most common etiologies of ventricular arrhythmias. The management of life-threatening sustained ventricular arrhythmias—including monomorphic and polymorphic ventricular tachycardia (VT) and ventricular fibrillation (VF)—is an important skill in critical care medicine. In the setting of pulseless VT or VF, guideline-directed ACLS—including defibrillation—should be implemented immediately. Diagnostic evaluation, including the selective use of blood tests, echocardiography, and coronary angiography, should be initiated simultaneous to treatment. Therapies should be tailored to the clinical situation, and may include electrolyte repletion, beta-adrenergic blockade, and the use of antiarrhythmic agents (particularly amiodarone), mechanical circulatory support, and radiofrequency catheter ablation.

Keywords

Ventricular arrhythmias Ventricular tachycardia Ventricular fibrillation Sudden cardiac death Radiofrequency ablation Antiarrhythmic agents Electrical storm Mechanical circulatory support 

References

  1. 1.
    Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, et al. Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med. 2012;367:2275–83.CrossRefGoogle Scholar
  2. 2.
    Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation. 2000;102:742–7.CrossRefGoogle Scholar
  3. 3.
    Chatzidou S, Kontogiannis C, Tsilimigras DI, Georgiopoulos G, Kosmopoulos M, Papadopoulou E, et al. Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator. J Am Coll Cardiol. 2018;71:1897–906.CrossRefGoogle Scholar
  4. 4.
    Brodine WN, Tung RT, Lee JK, Hockstad ES, Moss AJ, Zareba W, et al. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the multicenter automatic defibrillator implantation trial-ii). Am J Cardiol. 2005;96:691–5.CrossRefGoogle Scholar
  5. 5.
    Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the optic study: a randomized trial. JAMA. 2006;295:165–71.CrossRefGoogle Scholar
  6. 6.
    Desouza IS, Martindale JL, Sinert R. Antidysrhythmic drug therapy for the termination of stable, monomorphic ventricular tachycardia: a systematic review. Emerg Med J. 2013;68:392–7.Google Scholar
  7. 7.
    Levine JH, Massumi A, Scheinman MM, Winkle RA, Platia EV, Chilson DA, et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Coll Cardiol. 1996;27(1):67–75.CrossRefGoogle Scholar
  8. 8.
    Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med. 1994;121(7):529–35.CrossRefGoogle Scholar
  9. 9.
    Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med. 2002;346:884–90.CrossRefGoogle Scholar
  10. 10.
    Fotopoulos GD, Mason MJ, Walker S, Jepson NS, Patel DJ, Mitchell AG, et al. Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation. Heart. 1999;82(1):96–100.CrossRefGoogle Scholar
  11. 11.
    Tsai FC, Wang YC, Huang YK, Tseng CN, Wu MY, Chu JJ, et al. Extracorporeal life support to terminate refractory ventricular tachycardia. Crit Care Med. 2007;35:1673–6.CrossRefGoogle Scholar
  12. 12.
    Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM, Cooled RF Multi Center Investigators Group, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. J Am Coll Cardiol. 2000;35:1905–14.CrossRefGoogle Scholar
  13. 13.
    Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single center study. Circulation. 2008;117:462–9.CrossRefGoogle Scholar
  14. 14.
    Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375:111–21.CrossRefGoogle Scholar
  15. 15.
    Sacher F, Sobieszczyk P, Tedrow U, Eisenhauer AC, Field ME, Selwyn A, et al. Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm. 2008;5:62–8.CrossRefGoogle Scholar
  16. 16.
    Tokuda M, Sobieszczyk P, Eisenhauer AC, Kojodjojo P, Inada K, Koplan BA, et al. Transcoronary ethanol ablation for recurrent ventricular tachycardia after failed catheter ablation: an update. Circ Arrhythm Electrophysiol. 2011;4:889.CrossRefGoogle Scholar
  17. 17.
    Baher A, Shah DJ, Valderrabano M. Coronary venous ethanol infusion for the treatment of refractory ventricular tachycardia. Heart Rhythm. 2012;9:1637–9.CrossRefGoogle Scholar
  18. 18.
    Witt CM, Bolona L, Kinney MO, Moir C, Ackerman MJ, Kapa S, et al. Denervation of the extrinsic cardiac sympathetic nervous system as a treatment modality for arrhythmia. Europace. 2017;19:1075–83.CrossRefGoogle Scholar
  19. 19.
    Vaseghi M, Gima J, Kanaan C, Ajijola O, Marmureanu A, Mahajan A, et al. Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. Heart Rhythm. 2014;11:360.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of CardiologyScripps Memorial HospitalLa JollaUSA
  2. 2.Division of CardiologyWestchester Medical Center and New York Medical CollegeValhallaUSA

Personalised recommendations